Ironwood Pharmaceuticals | IRWD - Market Capitalization


Ironwood Pharmaceuticals reported $585.4M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Almirall EUR 2.76B 472.53M Dec/2025
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amarin USD 290M 51M Dec/2025
Ardelyx USD 1.48B 63M Mar/2026
Astellas Pharma JPY 3.94T 622.52B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Charles River Laboratories USD 10.39B 2.54B Jun/2026
Coherus Biosciences USD 172M 19M Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
MacroGenics USD 184M 82M Mar/2026
Pacira USD 998M 83M Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Takeda JPY 8.2T 809.7B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024